source
- Daiichi Sankyo posts 'extraordinary loss' of nearly $1BDaiichi Sankyo is scrapping plans to build antibody-drug conjugate manufacturing capacity and recorded an "extraordinary loss" of 149.4 billion Japanese yen ($950 million) after overpromising deman…Endpoints · 3mo ago↗ source
- Opinion: I’m fighting misinformation online. False hantavirus claims follow a now-familiar playbookThe cruise ship hantavirus outbreak is serious but limited. Online, it's another story.STAT · 3mo ago↗ source
- Former FDA leaders, pharma speak out on mifepristone“The fundamental question is: Who gets to regulate mifepristone?”STAT · 3mo ago↗ source